PEEK interbody devices market seen reaching $2.74 billion by 2030

The market for polyether ether ketone interbody devices is projected to grow from $1.92 billion in 2025 to $2.07 billion in 2026, with demand rising on spinal disorders, aging populations and more spinal fusion procedures. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region through 2030.

Why it matters: - PEEK interbody devices are used in spinal fusion surgery to stabilize the spine after damaged disc tissue is removed. - The market is growing as spinal disorders rise worldwide and more patients need surgical treatment. - The devices matter because they combine strength, body compatibility and clear imaging during follow-up scans.

What happened: - The Business Research Company released its Polyether Ether Ketone (PEEK) Interbody Devices Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The market is projected to rise from $1.92 billion in 2025 to $2.07 billion in 2026. - The forecast implies 7.8% growth from 2025 to 2026. - The market is expected to reach $2.74 billion by 2030 at a 7.3% compound annual growth rate. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The full report is available here. - A free sample is available here.

The details: - The market’s historical growth has been driven by degenerative disc disease, spinal trauma cases, traditional spinal implant use, an aging population and low awareness of advanced interbody devices. - PEEK is a high-performance polymer used in implants placed between vertebrae to support spinal fusion. - PEEK is valued for radiolucency, which allows clear imaging during recovery scans. - PEEK is also valued for mechanical strength that closely resembles natural bone. - Future growth is expected to be supported by innovation in PEEK materials and designs. - More minimally invasive surgery is expected to add demand. - Hospital infrastructure expansion is expected to support adoption. - Demand for customized implants is expected to increase. - Spinal fusion surgery volumes are increasing globally. - Anticipated product trends include better biocompatibility, radiolucent implants, personalized spinal implant solutions and wider use of minimally invasive techniques. - Spinal disorders affect bones, discs, nerves and muscles in the spine. - Sedentary lifestyles contribute to spinal disorders by weakening spinal muscles and increasing stress on the spine. - Spinal Cord Inc. reported nearly 18,000 new spinal cord injury cases in the United States in May 2023. - Spinal Cord Inc. also reported about 302,000 people living with spinal cord injuries in the United States.

Between the lines: - The report points to a market moving from broad implant adoption toward more specialized, imaging-friendly and patient-specific solutions. - Growth in minimally invasive procedures suggests surgeons and hospitals are seeking implants that fit newer operative techniques. - Regional leadership in North America and faster growth in Asia-Pacific indicate a mature core market alongside expanding demand in emerging healthcare systems.

What's next: - PEEK interbody device makers will likely focus on material upgrades, design improvements and customization. - Hospital and surgical adoption will likely track the broader shift toward minimally invasive spine care. - Asia-Pacific growth may create the strongest near-term expansion opportunity for manufacturers and suppliers. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel dashboards, hotspot infographics, and updated graphics and tables.